SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$3.69 USD
-0.06 (-1.60%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $3.63 -0.06 (-1.63%) 7:28 PM ET
2-Buy of 5 2
F Value B Growth F Momentum D VGM
SOPHiA GENETICS SA (SOPH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.25 | $7.00 | $5.00 | 66.67% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for SOPHiA GENETICS SA comes to $6.25. The forecasts range from a low of $5.00 to a high of $7.00. The average price target represents an increase of 66.67% from the last closing price of $3.75.
Analyst Price Targets (4 )
Broker Rating
SOPHiA GENETICS SA currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.60 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 60% and 20% of all recommendations. A month ago, Strong Buy made up 60%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 2 |
Buy | 1 | 1 | 1 | 2 | 2 |
Hold | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.60 | 1.60 | 1.60 | 1.30 | 1.38 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
6/27/2024 | Guggenheim Securities | Subbu Nambi | Not Available | Strong Buy |
4/1/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
1/19/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.60 |
ABR (Last week) | 1.60 |
# of Recs in ABR | 5 |
Average Target Price | $6.25 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 70 of 253 |
Current Quarter EPS Est: | -0.24 |
SOPH FAQs
SOPHiA GENETICS SA (SOPH) currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for SOPHiA GENETICS SA (SOPH) is $6.25. The current on short-term price targets is based on 1 reports.
The forecasts for SOPHiA GENETICS SA (SOPH) range from a low of $5 to a high of $7. The average price target represents a increase of $66.67 from the last closing price of $3.75.
The current UPSIDE for SOPHiA GENETICS SA (SOPH) is 66.67%
Based on short-term price targets offered by four analysts, the average price target for SOPHiA GENETICS SA comes to $6.25. The forecasts range from a low of $5.00 to a high of $7.00. The average price target represents an increase of 66.67% from the last closing price of $3.75.